Nasdaq - Delayed Quote
USD
T. Rowe Price Science & Tech (PRSCX)
69.12
+0.32
(+0.47%)
As of 8:10:22 AM EDT. Market Open.
Performance Overview
| Morningstar Return Rating | -- |
| YTD Return | 19.34% |
|---|---|
| 5y Average Return | 14.46% |
| Number of Years Up | 30 |
| Number of Years Down | 8 |
| Best 1Y Total Return (Oct 27, 2026) | 53.77% |
| Worst 1Y Total Return (Oct 27, 2026) | -- |
| Best 3Y Total Return | 53.77% |
| Worst 3Y Total Return | -0.11% |
Trailing Returns (%) Vs. Benchmarks
Monthly Total Returns
PRSCX
Category
- YTD
- 27.42%
- 12.31%
- 1-Month
- 4.50%
- 6.23%
- 3-Month
- -10.10%
- 8.63%
- 1-Year
- 31.95%
- 53.90%
- 3-Year
- 35.96%
- 27.50%
- 5-Year
- 16.61%
- 28.80%
- 10-Year
- 19.94%
- 18.74%
- Last Bull Market
- 50.57%
- 24.03%
- Last Bear Market
- -18.51%
- -20.41%
Annual Total Return (%) History
Year
PRSCX
Category
Past Quarterly Returns
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
|
2026
|
-7.22% | 52.76% | -10.10% | -- |
|
2025
|
-15.66% | 23.97% | 14.92% | 3.55% |
|
2024
|
16.97% | 8.28% | 1.43% | 9.19% |
|
2023
|
26.87% | 10.68% | -3.08% | 12.99% |
|
2022
|
-15.85% | -18.51% | -8.40% | 3.15% |
|
2021
|
7.68% | 7.60% | -6.45% | -2.67% |
|
2020
|
-16.01% | 30.73% | 12.09% | 18.47% |
|
2019
|
22.81% | 2.52% | 2.28% | 13.16% |
|
2018
|
5.39% | 5.65% | -2.31% | -14.49% |
|
2017
|
13.42% | 6.73% | 6.86% | 7.63% |
Rank in Category (By Total Return)
| YTD | 56 |
| 1-Month | 38 |
|---|---|
| 3-Month | 79 |
| 1-Year | 45 |
| 3-Year | 30 |
| 5-Year | 38 |
Load Adjusted Returns
| 1-Year | 31.95% |
| 3-Year | 35.96% |
|---|---|
| 5-Year | 16.61% |
| 10-Year | 19.94% |
Performance & Risk
| YTD Return | 19.34% |
| 5y Average Return | 14.46% |
| Rank in Category (ytd) | 56 |
| % Rank in Category (ytd) | -- |
| Beta (5Y Monthly) | 1.76 |
| Morningstar Risk Rating |
Fund Overview
| Category | Technology |
| Fund Family | T. Rowe Price |
| Net Assets | 14.35B |
| YTD Return | 27.42% |
| Yield | 0.00% |
| Morningstar Rating | |
| Inception Date | Sep 30, 1987 |
Fund Summary
The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the common stocks of companies expected to benefit from the development and use of science and/or technology. While most assets will typically be invested in U.S. common stocks, the fund may invest in foreign stocks, including issuers in emerging markets, in keeping with the fund's objective. The fund is non-diversified.
